Abbott presented Dr. Niraj Varma's SyncAV RCT results at the ESC 2026 Hotline Late Breaker session, involving 1,288 patients randomized across 96 global centres.
Public source
Publisher name
Public post
Achieving true left ventricular (LV) electrical resynchronization is the ultimate goal of Cardiac Resynchronization Therapy (CRT), yet conventional programming often fal…
Company
Abbott
- Industry
- Hospitals and Health Care
- Location
- Abbott Park, US
- Company size
- 10,001+ employees
About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.html Privacy Policy: https://abbo.tt/privacy
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
AtriCure, Inc.
AtriCure, Inc. presented new data at the ESC2026 meeting led by Associate Prof. Dr. Riyaz Kaba, demonstrating significantly greater freedom from atrial arrhythmias after hybrid epicardial-endocardial ablation compared to catheter ablation alone in patients with persistent and long-standing persistent Afib and reduced left ventricular ejection fraction.
Research & Knowledge
Philips
Philips published RECTIFY primary results showing electrophysiology consultations increased 76.9% and infectious disease consultations increased 49.2%
Research & Knowledge
Heart Rhythm Society
Heart Rhythm Society published a study presented at ESC 2026 titled Hot Line, which was misinterpreted and misrepresented by social media pundits.
Research & Knowledge
atHeart Medical
atHeart Medical shared mid-term data from the ASCENT ASD Study presented at PICS 2026 in San Diego, showing clinically significant closure and safety profile for the reSept ASD Occluder.
Research & Knowledge
Pulse Heart Institute